Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22642,178,0.77 [0.60-0.99],0.0417714084502012
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23671,192,0.76 [0.60-0.96],0.0211550798369103
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23428,1406,0.80 [0.73-0.88],2.659342796960228e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Candidiasis,23686,375,0.86 [0.72-1.04],0.1296463187779809
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22997,3466,0.82 [0.78-0.88],3.9180434076079774e-10
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22957,3486,0.80 [0.76-0.85],3.34408016522104e-13
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23468,1044,0.78 [0.71-0.87],5.1430481382952186e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23605,81,0.65 [0.47-0.89],0.0073124500284248
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21472,1119,0.78 [0.70-0.86],1.0438826068797658e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20714,1238,0.76 [0.69-0.84],1.3019687901237608e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,20441,252,0.76 [0.62-0.94],0.0102116942621102
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16644,2266,0.79 [0.73-0.85],3.6689955573982725e-11
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20364,402,0.73 [0.63-0.86],9.939661651609816e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23675,1251,0.78 [0.71-0.86],6.575989389841016e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Mycoses,23777,466,0.85 [0.72-1.00],0.0479171878866797
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22916,894,0.78 [0.70-0.87],1.7557412266543862e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23700,1236,0.80 [0.73-0.89],1.3031927420004907e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22618,194,0.72 [0.57-0.90],0.0049233885379708
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23816,51,0.83 [0.51-1.37],0.4761672657869203
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23542,1078,0.80 [0.72-0.89],3.227252377729228e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23597,73,1.05 [0.65-1.71],0.837918980458721
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23756,124,0.88 [0.64-1.22],0.4565524180749518
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23735,103,0.82 [0.58-1.14],0.2381714282848901
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22507,485,0.76 [0.66-0.89],0.0003894943006537
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22307,285,0.83 [0.67-1.03],0.0863208432682314
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22513,89,0.79 [0.55-1.14],0.2159380643853585
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23797,70,0.77 [0.52-1.14],0.1854127829617637
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23760,143,0.89 [0.65-1.21],0.4632827363595532
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral warts,23668,51,0.83 [0.51-1.36],0.4671033045288751
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23668,51,1.01 [0.58-1.77],0.9730933613885135
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign lipomatous neoplasm,23499,340,0.88 [0.72-1.08],0.2202100041314261
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23745,45,0.89 [0.52-1.55],0.6923345277053877
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23711,52,0.79 [0.50-1.24],0.3051103566419522
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23767,129,0.78 [0.58-1.05],0.1012528644193136
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23441,1643,0.91 [0.83-1.00],0.0524056768996613
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm of meninges,23816,33,0.57 [0.38-0.87],0.0086494956284311
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23752,65,0.99 [0.61-1.62],0.9782735623436768
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23801,78,0.66 [0.48-0.91],0.0105444060489328
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23791,440,0.83 [0.70-0.99],0.0337613733870589
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Caecum,23786,340,0.74 [0.62-0.88],0.0005385491608278
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23686,81,1.04 [0.66-1.64],0.8637003697715945
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Descending colon,23783,277,0.94 [0.74-1.18],0.566597376588011
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Rectum,23743,419,0.90 [0.75-1.08],0.2507259750220626
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23691,733,0.97 [0.84-1.12],0.7036070707551556
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23773,562,0.88 [0.75-1.02],0.0911008633280903
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",18492,70,1.11 [0.67-1.84],0.6764093009231965
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",18493,71,0.84 [0.55-1.29],0.4280715314638622
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23785,101,0.71 [0.53-0.97],0.0291305130190496
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Haemangioma, any site",23785,99,0.73 [0.53-0.99],0.0457781337805389
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Lung cancer and mesothelioma,15844,340,0.60 [0.51-0.71],2.115869970816489e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Lymphoid leukaemia,18487,65,1.08 [0.64-1.80],0.7803920634298102
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18620,198,0.81 [0.63-1.04],0.0967122401602393
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",18710,288,1.17 [0.91-1.52],0.2220540139971388
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",18517,95,0.91 [0.62-1.34],0.6370102760917183
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",18567,145,0.79 [0.59-1.05],0.1076064706674145
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",18561,139,1.02 [0.73-1.43],0.9056608812181656
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",18505,83,0.92 [0.60-1.41],0.7050177875733434
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19824,1402,0.98 [0.89-1.09],0.7729056195783667
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",18565,143,0.78 [0.59-1.04],0.0906363287040172
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",18528,106,1.03 [0.69-1.53],0.8916021671119663
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,18552,130,1.09 [0.75-1.58],0.6538795357464875
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Melanocytic naevi,23687,170,1.15 [0.83-1.60],0.3935648507214709
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Melanocytic naevi of trunk,23783,95,1.15 [0.74-1.77],0.5409807721067499
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Melanoma in situ,18455,74,0.72 [0.50-1.03],0.0741080714954519
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",18522,100,0.92 [0.63-1.35],0.6689860693748668
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18589,167,0.86 [0.65-1.14],0.2843629091783186
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18636,214,0.62 [0.51-0.76],2.9669948466400167e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",18524,102,0.78 [0.56-1.10],0.1600084520128359
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Other benign neoplasms of skin,23682,140,0.87 [0.64-1.19],0.3810189832635239
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19630,1208,0.93 [0.83-1.04],0.2304403594719562
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19708,1286,0.94 [0.84-1.05],0.284373121492482
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23539,309,0.79 [0.65-0.96],0.0168978735217545
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22082,118,0.81 [0.59-1.12],0.2103202003964588
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23303,73,0.79 [0.53-1.16],0.2250282860977367
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23253,2785,0.82 [0.77-0.88],4.00661055312205e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22531,60,0.63 [0.44-0.90],0.011083862320824
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23390,53,0.67 [0.45-0.99],0.0442577646146417
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23436,1472,0.77 [0.71-0.84],4.731113054706057e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23434,1470,0.77 [0.71-0.84],5.441960859257876e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22068,104,0.87 [0.60-1.25],0.4452165786041773
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23577,1106,0.82 [0.74-0.91],0.000236642837766
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23442,105,0.90 [0.62-1.29],0.5516991965027931
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23306,76,1.22 [0.75-1.99],0.4328109216718639
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23291,61,1.04 [0.62-1.75],0.8862223895309049
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23651,314,0.87 [0.71-1.07],0.1780457499756589
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23718,49,0.61 [0.42-0.86],0.0055680819842189
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23594,257,0.90 [0.71-1.14],0.37112737888482
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22550,79,0.67 [0.49-0.94],0.0190529175870076
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,17553,375,0.70 [0.59-0.82],1.6242414744435008e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21773,163,0.62 [0.51-0.76],3.4014248932125927e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21800,190,0.68 [0.55-0.84],0.0004040413821232
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,17232,54,0.59 [0.41-0.84],0.0035902854866396
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22440,64,0.76 [0.50-1.14],0.1828772417764466
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21671,225,0.72 [0.58-0.89],0.0028650209481483
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23312,617,0.81 [0.70-0.94],0.0045887933075746
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22936,241,1.05 [0.80-1.38],0.7275389138563415
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22865,170,0.85 [0.64-1.13],0.2662476191540976
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23514,1138,0.81 [0.73-0.90],5.953915870159355e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20371,1094,0.79 [0.72-0.88],7.1427042341019634e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",17253,75,1.07 [0.65-1.74],0.7988853571177849
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22944,39,0.56 [0.39-0.81],0.0018110696898956
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,17450,272,0.64 [0.54-0.77],9.642349174358295e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,17254,76,1.37 [0.81-2.32],0.2334682051028841
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21058,3880,0.83 [0.79-0.88],9.147459573825372e-10
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,17363,185,0.62 [0.50-0.75],2.7624074204943003e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17746,568,0.73 [0.64-0.84],5.926688919907606e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23757,277,0.75 [0.62-0.92],0.0043327101333848
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23571,91,0.76 [0.54-1.06],0.1065126507396111
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,17329,151,0.83 [0.62-1.11],0.2147517111179883
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",17244,66,0.78 [0.50-1.22],0.2832420927596439
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23640,735,0.84 [0.74-0.96],0.0083319845050474
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17485,307,0.62 [0.53-0.73],1.1945299250271496e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17559,381,0.66 [0.56-0.77],1.7890114558855385e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17906,728,0.72 [0.64-0.81],4.5478999864741934e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,17322,144,1.16 [0.80-1.67],0.4307171421769789
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23564,84,0.76 [0.53-1.09],0.1344480035812893
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17751,573,0.67 [0.59-0.77],3.591711854175044e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17566,388,0.62 [0.54-0.71],4.3877271685897805e-11
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21514,68,0.75 [0.50-1.13],0.1706612628490168
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22378,5200,0.83 [0.79-0.87],3.567820918199331e-13
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22925,20,0.58 [0.34-0.99],0.0443230905144895
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22926,21,1.29 [0.49-3.38],0.6059481795383652
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23643,1778,0.86 [0.80-0.94],0.0006913418584098
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23640,1774,0.87 [0.80-0.94],0.0008502288893605
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22928,23,0.92 [0.41-2.04],0.8309575047849991
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23543,802,0.85 [0.75-0.97],0.0135563006904505
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18799,1621,0.70 [0.65-0.76],2.5795425518570378e-18
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23805,265,0.94 [0.74-1.19],0.6111768353283216
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22802,107,0.99 [0.67-1.46],0.9588188725720156
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22817,76,0.69 [0.49-0.97],0.0320980204165649
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22823,82,1.23 [0.76-1.99],0.3974822887274648
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",17243,65,0.74 [0.49-1.12],0.156207724760947
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21025,168,0.95 [0.71-1.28],0.7369291018039104
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2510,121,0.79 [0.59-1.06],0.1132550441605017
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2674,318,0.87 [0.71-1.06],0.1655654777272934
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20956,99,0.78 [0.56-1.08],0.1374727718879215
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2468,81,0.80 [0.55-1.16],0.2393715900806319
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23025,2168,0.96 [0.88-1.04],0.3395521780608372
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23057,362,0.81 [0.67-0.98],0.0324933420600023
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21687,241,0.97 [0.75-1.24],0.7888877213377694
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17978,800,0.74 [0.65-0.83],5.393713207046674e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23691,253,0.70 [0.58-0.85],0.0002270730705464
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22582,271,0.73 [0.60-0.90],0.0025740777126944
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Angina pectoris,20896,1488,0.80 [0.73-0.88],2.4047622251416497e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22692,381,0.71 [0.61-0.84],5.755656220003858e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22395,84,0.65 [0.47-0.90],0.0094131777676643
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22561,250,0.62 [0.52-0.74],9.248054381609556e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,13948,2315,0.80 [0.74-0.86],1.2856702947174663e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,AV-block,19154,623,0.83 [0.72-0.96],0.0135046016633868
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23740,533,0.93 [0.79-1.10],0.4213188107839722
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Cardiac arrest,11882,249,0.70 [0.57-0.85],0.0003271730269682
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18734,203,0.71 [0.57-0.89],0.002225226134099
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",18643,112,0.68 [0.52-0.90],0.0060208529210226
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23817,68,0.60 [0.43-0.83],0.0021793904955539
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Conduction disorders,19901,1370,0.80 [0.73-0.88],7.64331844357549e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22005,2621,0.83 [0.77-0.89],1.800816714183522e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20059,7761,0.89 [0.85-0.93],3.606936533866214e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22581,277,0.71 [0.59-0.85],0.0001747123606517
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Endocarditis,18614,83,0.77 [0.53-1.12],0.1719181745529203
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23507,1330,0.75 [0.69-0.82],1.073457368321279e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Hypertension,21259,6765,0.88 [0.84-0.92],1.1375412289675274e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21282,6788,0.88 [0.84-0.92],2.229562957702977e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23584,113,0.95 [0.66-1.37],0.7814674148441336
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14677,183,0.56 [0.47-0.67],1.8738995289523768e-10
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14663,169,0.68 [0.53-0.85],0.0011066898729564
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Hypotension,23669,1239,0.78 [0.70-0.85],1.947748905675e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22747,119,0.91 [0.64-1.30],0.6163990600873996
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22149,2741,0.83 [0.77-0.88],3.26007145920997e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23386,652,0.91 [0.78-1.06],0.2112165090874878
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Left bundle-branch block,18952,421,0.83 [0.70-0.99],0.0352758834492612
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23090,1060,0.85 [0.76-0.95],0.0051158450135079
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",20328,920,0.81 [0.72-0.90],0.0002601663428716
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23654,221,0.91 [0.71-1.17],0.4663952526053744
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23765,371,0.81 [0.68-0.97],0.0237654920586048
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Oesophageal varices,22376,72,0.80 [0.53-1.19],0.2696872792712192
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other aneurysm,22409,98,0.65 [0.49-0.88],0.0044029245670308
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,19012,481,0.88 [0.74-1.05],0.1569662651168649
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22446,135,0.69 [0.53-0.91],0.0077388707214348
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22597,286,0.77 [0.63-0.95],0.0124614263046178
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,18722,191,0.86 [0.66-1.12],0.2518642849877718
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other disorders of veins,22402,98,0.76 [0.55-1.05],0.0969409912447342
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22354,50,0.96 [0.55-1.68],0.8947635133447276
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22223,88,0.94 [0.62-1.43],0.7815652369968893
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22411,107,0.68 [0.51-0.90],0.0068444791042722
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19780,1249,0.77 [0.70-0.85],4.225668356348701e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22496,66,1.14 [0.68-1.92],0.6109789429384946
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22883,572,0.73 [0.64-0.84],1.3027041327962829e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23175,366,0.63 [0.55-0.73],7.956437448299506e-10
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22802,667,0.81 [0.71-0.93],0.0033537159752706
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,12014,381,0.71 [0.61-0.84],3.8297458907147406e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22795,530,0.71 [0.62-0.82],1.3601798240021315e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22660,356,0.75 [0.63-0.88],0.0007238947437038
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23302,493,0.96 [0.80-1.14],0.6142328102622039
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23756,715,0.79 [0.70-0.90],0.0004787274579879
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Right bundle-branch block,19004,473,0.74 [0.64-0.87],0.0001405713936237
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23173,364,0.63 [0.55-0.73],6.867028880019322e-10
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22360,225,0.67 [0.55-0.81],3.608726046970318e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23370,742,0.90 [0.78-1.03],0.1402092789458176
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23354,772,0.91 [0.79-1.04],0.1800957816440163
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22724,48,1.06 [0.59-1.93],0.8358551080003933
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22426,116,0.72 [0.54-0.97],0.0282804406580759
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22986,252,0.99 [0.77-1.27],0.9439232249588984
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22344,314,0.82 [0.67-1.00],0.0466639689760594
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Varicose veins,22687,383,0.85 [0.71-1.02],0.0845290173887879
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22330,73,0.85 [0.55-1.30],0.4480796717170214
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23577,778,0.85 [0.75-0.97],0.0128571935685543
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23619,497,0.75 [0.65-0.86],5.470220890778086e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20472,973,0.83 [0.75-0.93],0.0017581297371449
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Any mental disorder,23128,3629,0.84 [0.79-0.89],2.428454746443877e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23556,585,0.72 [0.63-0.81],2.7461127236517004e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20672,1173,0.79 [0.72-0.87],2.75526000361436e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19584,85,0.76 [0.53-1.10],0.1426254608968588
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Smoking dependency,23166,1533,0.81 [0.74-0.88],9.305145949312256e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21367,1868,0.79 [0.73-0.85],1.695822192445541e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Vascular dementia,23304,150,0.66 [0.51-0.84],0.0009861372416634
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Alzheimer disease,23815,298,0.87 [0.70-1.09],0.2310054537025099
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",15822,58,0.88 [0.52-1.48],0.6209424766511473
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Bell's palsy,22448,75,1.03 [0.65-1.63],0.905273529265044
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22712,339,0.80 [0.67-0.97],0.0196597133569226
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Cerebral cysts,23409,239,0.75 [0.61-0.92],0.0072518018288821
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23731,366,0.78 [0.65-0.93],0.0053541308703453
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23308,60,0.82 [0.52-1.31],0.41529222322735
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23797,73,0.65 [0.47-0.90],0.0088160241125775
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23262,92,0.71 [0.51-0.98],0.0385883529288974
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Epilepsy,22198,288,0.77 [0.63-0.93],0.0075485436198836
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23279,1369,0.89 [0.81-0.99],0.0253358679582805
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23780,681,0.93 [0.80-1.08],0.3566957544725062
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23270,2211,0.77 [0.72-0.83],4.0175063047886026e-13
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Generalized epilepsy,23424,59,0.65 [0.45-0.92],0.0166640341033959
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Hemiplegia,23647,282,0.81 [0.66-1.00],0.0507995438101632
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Hydrocephalus,23226,56,0.84 [0.52-1.35],0.4792059731447957
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23798,58,1.03 [0.61-1.75],0.90760387829665
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22393,20,1.14 [0.44-2.94],0.7848472301216299
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22469,96,0.91 [0.62-1.34],0.6446789312655035
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Memory loss,23145,119,0.85 [0.61-1.19],0.3413259640405111
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Migraine,22106,196,1.01 [0.76-1.34],0.9453587281904144
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23792,177,0.98 [0.73-1.31],0.8688129718533171
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Motor neuron disease,15929,152,0.96 [0.70-1.32],0.7957442993996989
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23705,64,0.56 [0.42-0.74],5.858186023454663e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23348,975,0.90 [0.80-1.01],0.0780358411140253
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Neurological diseases,22503,3678,0.88 [0.82-0.93],1.728561173725321e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23487,239,0.92 [0.72-1.19],0.5295563004553516
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22764,391,0.87 [0.73-1.05],0.1454668932487242
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23722,349,0.80 [0.67-0.96],0.0165017677032739
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18670,621,0.78 [0.68-0.90],0.0005240408196005
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23250,80,0.78 [0.54-1.13],0.1943441190912382
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23325,155,0.79 [0.60-1.04],0.0928128771228808
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23235,136,1.00 [0.71-1.40],0.9834371212963454
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22467,94,0.93 [0.63-1.37],0.7177217234995604
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other headache syndromes,21947,37,0.89 [0.49-1.62],0.6942362031813174
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other neurological diseases,23697,527,0.81 [0.69-0.94],0.0050913134688882
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other sleep disorders,22615,705,0.87 [0.76-1.00],0.0474849519395357
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Parkinson's disease,23794,536,0.91 [0.77-1.08],0.2739490471021009
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23198,28,0.71 [0.40-1.27],0.2513545800913314
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Restless leg syndrome,23816,46,0.88 [0.51-1.51],0.6362219587876481
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Sleep apnoea,23512,634,0.86 [0.75-1.00],0.0434249861688555
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23431,58,1.11 [0.64-1.93],0.7075781843717659
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23798,178,0.97 [0.72-1.30],0.8336784856118203
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22408,35,0.93 [0.49-1.79],0.8361478353628168
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23815,301,0.88 [0.70-1.10],0.25411684493832
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23273,146,0.71 [0.54-0.93],0.0120026338788733
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23265,88,0.74 [0.52-1.05],0.0886180377094401
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23472,300,1.05 [0.83-1.33],0.6789276597926057
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23616,292,0.80 [0.65-0.97],0.0238226063302541
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22943,44,0.78 [0.47-1.29],0.3306143072602754
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22958,59,0.77 [0.51-1.18],0.2284975560872838
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23726,44,0.81 [0.48-1.37],0.4421480198790853
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23586,124,1.02 [0.71-1.47],0.915655945846537
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2472,83,0.82 [0.57-1.19],0.2938832056333678
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3008,128,0.80 [0.59-1.07],0.1360652599107302
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23268,91,0.87 [0.59-1.28],0.4909216544061402
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23568,996,0.91 [0.81-1.03],0.1219274602862495
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23511,612,0.91 [0.78-1.07],0.2536971800631614
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23042,143,0.98 [0.70-1.37],0.9163697417760154
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23741,569,1.10 [0.92-1.31],0.3057624231316048
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23813,63,1.25 [0.72-2.18],0.4228049264032807
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23675,503,1.10 [0.91-1.32],0.3410902583714232
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23776,314,0.79 [0.65-0.97],0.0204038016789019
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23725,148,0.91 [0.67-1.24],0.5433148581840443
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22978,79,1.40 [0.83-2.34],0.2040190019410258
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22985,86,0.79 [0.54-1.16],0.2328927863402793
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22943,44,0.81 [0.47-1.37],0.427700910170536
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23720,679,1.01 [0.87-1.18],0.871652903226062
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23224,183,1.19 [0.86-1.64],0.2922928815359717
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23201,29,2.50 [0.97-6.40],0.0568332486715744
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23559,97,0.72 [0.53-1.00],0.0473059213365536
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23685,223,0.84 [0.66-1.07],0.1507127424620766
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23344,172,1.09 [0.79-1.50],0.5977064297776965
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23660,83,1.13 [0.71-1.80],0.6142089781228658
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23500,459,1.11 [0.91-1.35],0.3206768299542148
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23308,131,0.77 [0.58-1.02],0.0707721367758514
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22434,1788,1.06 [0.96-1.17],0.2283936478676431
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23656,194,0.90 [0.69-1.18],0.4490673189231638
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23800,145,1.21 [0.85-1.74],0.2913430555602708
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23317,418,0.94 [0.78-1.14],0.522580679143275
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23528,66,0.67 [0.47-0.97],0.0318765417139106
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23804,54,1.50 [0.80-2.80],0.2080201838757783
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22975,76,0.77 [0.52-1.14],0.1981260594531794
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23037,138,1.01 [0.72-1.42],0.9582529608242176
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22698,126,0.81 [0.59-1.11],0.1933625967699295
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23220,48,1.08 [0.60-1.96],0.7959637392347026
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22635,63,1.32 [0.75-2.32],0.3345160914869564
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23091,50,0.72 [0.46-1.12],0.1424485370835668
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23250,209,0.96 [0.73-1.26],0.7658114349576461
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23017,118,0.71 [0.53-0.94],0.0168549081006017
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22694,122,1.05 [0.72-1.51],0.8043264188040151
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22664,92,0.69 [0.50-0.95],0.0229803999075314
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22121,1475,1.03 [0.93-1.14],0.6077872180868933
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22956,57,0.98 [0.58-1.66],0.9375950144760438
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23568,391,0.83 [0.69-0.99],0.0403687088703467
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23248,71,1.14 [0.69-1.90],0.6030101867188908
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23346,169,0.83 [0.63-1.09],0.1745079593310373
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23640,57,1.08 [0.62-1.88],0.775254513704509
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23773,121,1.02 [0.71-1.48],0.9007459195526568
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23683,111,0.98 [0.68-1.43],0.93708085381786
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23633,50,1.54 [0.80-2.97],0.1988933348086048
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23636,53,1.00 [0.58-1.73],0.9962965316293744
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23722,965,0.82 [0.73-0.91],0.0004414860147439
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23474,717,0.84 [0.73-0.96],0.0118277957952507
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22888,131,0.64 [0.50-0.81],0.0002545549834469
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22840,83,1.01 [0.65-1.57],0.974703386269276
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Acute pharyngitis,23605,63,0.92 [0.57-1.48],0.7242278446559605
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23730,188,0.86 [0.66-1.11],0.2414054456576771
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23602,60,0.86 [0.54-1.37],0.5350603133810304
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,All influenza,21520,109,0.66 [0.50-0.87],0.0029621184510007
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),21517,106,0.65 [0.49-0.85],0.0018538440632469
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Allergic asthma (mode),15608,104,1.10 [0.73-1.65],0.6600720653295411
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Allergic rhinitis,23707,266,1.16 [0.89-1.51],0.2617998043943914
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16584,1429,0.81 [0.74-0.88],2.5701491609942394e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16908,1404,0.80 [0.73-0.87],7.898690543931126e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23429,151,0.77 [0.59-1.02],0.0695427181830341
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21506,95,0.73 [0.52-1.02],0.0649819042796589
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Bronchiectasis,20704,289,0.66 [0.55-0.78],2.7352730608936587e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20458,43,0.98 [0.53-1.82],0.9448429302210392
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22960,2545,0.78 [0.73-0.84],4.030839351590159e-13
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22370,79,1.39 [0.84-2.31],0.2033390001596283
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,22452,161,0.90 [0.67-1.20],0.4702926110721293
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23591,1300,0.70 [0.64-0.76],4.369006918596718e-16
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,22431,140,0.97 [0.70-1.34],0.8372440811399282
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21799,5267,0.80 [0.76-0.84],3.20870664691839e-20
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22683,392,0.86 [0.72-1.03],0.0969457212367752
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Early onset COPD,22595,304,0.69 [0.59-0.82],1.4809336941541254e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Emphysema,20762,347,0.65 [0.55-0.77],2.8080215315135605e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22881,335,0.74 [0.61-0.88],0.0008667678086179
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23565,2154,0.76 [0.71-0.82],5.4988905858083086e-14
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,22910,364,0.71 [0.60-0.84],6.343129831411164e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Later onset COPD,22748,996,0.69 [0.62-0.76],6.366043999323636e-13
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23799,426,0.75 [0.64-0.88],0.0004276122634708
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Nasal polyp,22435,144,0.80 [0.60-1.06],0.1256802097054319
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23547,1001,0.79 [0.71-0.88],1.870951187345861e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,23534,2190,0.76 [0.71-0.82],1.208784592446304e-13
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23162,871,0.91 [0.80-1.04],0.1601683725366358
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other pleural conditions,21410,66,0.69 [0.48-1.01],0.0584132039149458
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23720,448,0.72 [0.62-0.84],3.502156107164572e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23692,1384,0.77 [0.70-0.84],7.632039460663702e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pleural effusion,22467,1123,0.77 [0.69-0.85],1.8158355473201208e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pleural plaque,21609,265,0.63 [0.52-0.75],1.699259608890424e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23301,1890,0.75 [0.69-0.81],4.720889653455484e-14
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23697,324,0.77 [0.64-0.93],0.007183976700775
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pneumothorax,21484,140,0.77 [0.58-1.03],0.0816543994336593
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pollen allergy,23800,231,1.14 [0.86-1.50],0.3693979442255534
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pulmonary oedema,23340,68,0.73 [0.49-1.08],0.1134316372974983
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Respiratory insufficiency,15560,56,0.55 [0.39-0.76],0.0004120657897948
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23529,983,0.79 [0.71-0.88],2.3130032801707453e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22559,268,1.16 [0.89-1.51],0.2627293091552983
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Viral pneumonia,21692,281,0.81 [0.66-1.00],0.0518462272119364
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23447,238,0.84 [0.67-1.06],0.1397939592847183
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10369,118,0.76 [0.56-1.04],0.0829053708151402
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16615,89,0.82 [0.57-1.18],0.2907419539929701
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Acute appendicitis,23680,144,1.11 [0.78-1.57],0.5632457820936134
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Acute gastritis,17969,90,0.69 [0.50-0.95],0.0220591060860268
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,22457,203,0.81 [0.64-1.03],0.0872076212851043
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Acute peritonitis,23459,100,1.05 [0.70-1.59],0.801713889654946
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22917,117,0.73 [0.55-0.97],0.027736963105731
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Barrett oesophagus,18407,528,0.82 [0.70-0.96],0.0110270523090866
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22376,122,0.78 [0.57-1.05],0.1002250489536563
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23408,122,0.78 [0.57-1.06],0.1096684990994909
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Cholecystitis,22473,219,0.91 [0.71-1.18],0.4750851465899224
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Cholelithiasis,23043,789,0.79 [0.70-0.89],0.0001362162446536
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Chronic gastritis,18144,265,1.08 [0.84-1.39],0.5559642089381095
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22310,56,0.64 [0.44-0.92],0.0169163785013373
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23607,136,0.91 [0.66-1.25],0.5542018484984783
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Coeliac disease,22175,95,0.70 [0.51-0.94],0.0182743176695661
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Collagenous colitis,22373,48,0.64 [0.43-0.96],0.0313759145055233
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23648,222,0.89 [0.69-1.14],0.3449886009425418
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Constipation,23653,1597,0.81 [0.75-0.89],4.613794246491724e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Crohn disease,22418,93,0.75 [0.54-1.06],0.1071995204678422
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23471,67,1.07 [0.64-1.77],0.7958365598193334
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22403,78,0.75 [0.52-1.08],0.1249395649089646
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Dental caries,23169,228,0.83 [0.66-1.04],0.1008077389320808
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20173,1948,0.87 [0.80-0.94],0.0008450480399305
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of appendix,23711,175,1.12 [0.82-1.54],0.4795476312792328
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of liver,23674,874,0.85 [0.76-0.96],0.0106984215277472
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21819,3940,0.91 [0.85-0.96],0.001171101769452
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23455,514,0.92 [0.78-1.09],0.3360449525927741
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23766,407,0.89 [0.74-1.06],0.1921877002966829
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23052,111,0.78 [0.57-1.07],0.1236882041114652
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22908,67,1.13 [0.68-1.89],0.6421958822992935
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23497,1417,0.87 [0.79-0.95],0.0034490164863488
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of tongue,22928,108,1.21 [0.80-1.83],0.3662483307145634
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23445,1191,0.80 [0.73-0.89],1.6054265242793884e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19580,3054,0.86 [0.81-0.92],5.666425767948415e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,18147,268,0.92 [0.73-1.17],0.5128884900462269
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23700,212,1.06 [0.80-1.40],0.7011732276877398
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23741,45,1.46 [0.74-2.90],0.2727210069147918
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22959,159,1.00 [0.73-1.37],0.9857799519440372
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16707,181,0.87 [0.67-1.14],0.3216577498297709
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,18304,425,1.04 [0.86-1.27],0.6752183140800014
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastric ulcer,18244,365,0.80 [0.67-0.95],0.0133454120255951
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20038,2159,0.90 [0.83-0.97],0.0077414092933056
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18474,595,0.85 [0.73-0.98],0.0270374174452131
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18192,7985,0.92 [0.88-0.96],0.0001771019573549
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,GI-bleeding,23258,1178,0.88 [0.80-0.99],0.0253554316024397
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22987,46,0.91 [0.53-1.57],0.7308385526115451
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17495,1236,0.90 [0.81-1.01],0.0625864155558417
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22886,86,0.97 [0.64-1.48],0.8913810520526285
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Hernia,21758,3533,0.89 [0.84-0.95],0.0003090411437949
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Impacted teeth,23744,42,1.36 [0.68-2.72],0.3827073778968159
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Impaction of intestines,16571,45,0.74 [0.45-1.21],0.2256012173066052
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Inguinal hernia,19854,1629,0.88 [0.81-0.97],0.0076129079668607
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",18421,196,0.81 [0.64-1.04],0.1003309406744595
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16615,89,0.79 [0.55-1.13],0.1969366588290174
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22188,108,0.73 [0.54-0.98],0.0353586911631636
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16798,272,0.74 [0.61-0.90],0.0021688128400292
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23773,378,0.95 [0.78-1.16],0.6107753478303082
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23006,681,0.82 [0.72-0.94],0.0054589680129857
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23214,889,0.82 [0.72-0.92],0.0007620973619249
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18094,215,0.90 [0.70-1.17],0.4468868467031681
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Oesophagitis,18509,630,0.88 [0.76-1.03],0.1048840327643389
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23765,114,1.33 [0.88-2.01],0.1827695272708729
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,18297,72,0.79 [0.53-1.17],0.2422096186477514
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17961,1435,0.88 [0.80-0.96],0.0064802243148391
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22515,261,0.76 [0.62-0.93],0.008827158268136
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22377,123,0.84 [0.61-1.16],0.2966150777467588
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,18408,1882,0.90 [0.83-0.98],0.0159303714037943
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,21993,5467,0.90 [0.85-0.94],1.743233903912531e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22893,180,1.39 [0.99-1.94],0.0559859629834401
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of liver,23496,696,0.84 [0.74-0.96],0.0124248650489321
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18618,739,0.81 [0.71-0.92],0.0011928716929532
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22396,142,0.75 [0.57-0.98],0.0371942338622468
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23692,333,0.84 [0.69-1.02],0.0851366904161879
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18687,808,0.81 [0.72-0.92],0.0011715566070026
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23270,1190,0.89 [0.80-0.99],0.0255912433850181
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23119,178,1.06 [0.78-1.44],0.6956725235835031
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18161,1635,0.80 [0.73-0.87],1.8264261807108506e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19757,1878,0.89 [0.82-0.97],0.0092740367148341
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22899,99,1.36 [0.87-2.13],0.1829093625972175
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23103,778,0.82 [0.72-0.93],0.002552681836382
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16878,352,0.78 [0.65-0.93],0.0065365511229396
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23732,55,1.36 [0.74-2.49],0.3165104284636585
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17002,476,0.77 [0.66-0.90],0.0010032230777218
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22244,164,0.87 [0.66-1.16],0.3580849416917494
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23803,44,1.12 [0.59-2.10],0.7331223055745042
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22951,107,1.05 [0.71-1.56],0.8018428560411393
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Toxic colitis,22371,46,0.86 [0.49-1.50],0.5991707509625663
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18181,302,0.90 [0.72-1.12],0.3317795368309357
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,22473,148,0.65 [0.52-0.82],0.0003262100204937
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22449,124,0.73 [0.55-0.97],0.0324928332273928
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Umbilical hernia,18591,366,0.89 [0.73-1.08],0.2245140808652032
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16684,158,0.76 [0.59-0.99],0.0416169418424321
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Ventral hernia,18484,259,1.06 [0.83-1.37],0.6329326661110866
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Volvulus,16600,74,0.66 [0.47-0.91],0.011549065335492
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23740,332,1.10 [0.87-1.38],0.4392971094311604
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23502,69,0.95 [0.60-1.51],0.8347243005056757
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21819,98,1.46 [0.92-2.33],0.110523874737769
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23082,768,0.84 [0.74-0.96],0.0083260950415964
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22514,200,0.85 [0.67-1.10],0.2144982530586744
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22187,466,0.81 [0.69-0.96],0.0128649765482232
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23524,270,0.78 [0.63-0.95],0.014360081021915
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23727,473,0.78 [0.67-0.90],0.0011343383437288
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23297,43,0.84 [0.49-1.43],0.5154217890675772
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22328,3188,0.90 [0.84-0.96],0.001435373721954
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23368,405,0.84 [0.70-1.00],0.0542408289836906
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23258,295,0.85 [0.69-1.04],0.1130223913051885
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23356,1042,0.87 [0.77-0.97],0.0111733002265783
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23806,29,0.62 [0.39-1.00],0.0489052892859761
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21744,23,0.60 [0.36-0.98],0.0413986049405749
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23019,56,0.75 [0.49-1.15],0.1909682459027137
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23519,265,0.77 [0.63-0.95],0.0145336839706558
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22201,480,1.05 [0.87-1.26],0.6417865544162904
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21801,80,0.74 [0.52-1.05],0.0866110125918584
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23750,82,0.96 [0.63-1.47],0.8522346017341972
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22533,219,0.75 [0.61-0.93],0.0077240052249163
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23648,215,1.09 [0.82-1.45],0.5368912265876273
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23326,72,0.68 [0.48-0.95],0.024081170942253
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21788,67,1.27 [0.74-2.19],0.3781065934322091
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23357,1636,0.90 [0.82-0.99],0.0269525463364796
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22242,521,0.99 [0.83-1.17],0.8836954125052193
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21804,83,0.74 [0.52-1.05],0.0921618381521099
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23727,294,0.99 [0.79-1.25],0.9540098275833048
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23308,54,0.86 [0.52-1.41],0.5430663353880723
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23692,259,1.07 [0.83-1.38],0.6222096824694083
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23760,352,1.11 [0.89-1.40],0.3487187355985667
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21812,91,1.75 [1.06-2.89],0.0300339322339644
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21993,272,1.15 [0.89-1.49],0.2865399560004213
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23753,345,1.09 [0.87-1.37],0.4414754182509465
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21990,269,0.71 [0.59-0.85],0.0001781932675907
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23792,124,0.79 [0.58-1.07],0.1260084263734116
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20571,91,0.68 [0.50-0.93],0.015464295639756
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21734,4782,0.89 [0.84-0.94],1.446525395566368e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20320,3368,0.90 [0.84-0.96],0.0012844091225352
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20551,71,0.66 [0.47-0.92],0.0151812863294067
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20910,151,0.81 [0.61-1.08],0.1463979009072643
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20904,145,0.79 [0.59-1.04],0.0920457817543894
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23612,68,0.85 [0.56-1.31],0.4630005103227465
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20840,81,0.82 [0.54-1.24],0.3448513892481101
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17819,867,0.93 [0.81-1.05],0.2461450059414672
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23698,149,0.88 [0.65-1.20],0.4257093070499524
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21031,272,0.82 [0.66-1.01],0.0638683076056206
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20271,6262,0.88 [0.84-0.93],3.11983645673615e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22748,90,0.79 [0.56-1.11],0.17407180975386
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20647,167,0.68 [0.54-0.86],0.0014769848835464
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20909,429,0.95 [0.79-1.14],0.5838275999842448
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22995,2236,0.87 [0.81-0.94],0.0006865011628153
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20844,364,0.91 [0.74-1.11],0.3386941374710814
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20534,54,0.68 [0.46-1.00],0.0522276428822322
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20572,92,1.41 [0.88-2.27],0.1523028556818369
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23499,32,0.73 [0.42-1.28],0.2769611728052755
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18414,1462,0.83 [0.76-0.91],7.945327485480783e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17939,987,0.80 [0.72-0.89],5.949379486516766e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23676,973,0.80 [0.71-0.89],4.524131268377704e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16999,47,1.19 [0.63-2.25],0.5812184432750774
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),17032,80,1.31 [0.79-2.17],0.2879534531229504
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20754,274,0.91 [0.72-1.14],0.3932497589524825
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17578,626,0.89 [0.77-1.04],0.1352971687061545
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20802,43,0.65 [0.42-1.02],0.060550019531407
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21290,531,0.84 [0.72-0.98],0.0312739247971193
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21025,266,0.86 [0.69-1.08],0.1965236036919969
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17535,583,0.90 [0.77-1.05],0.19449759983118
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20545,65,0.97 [0.60-1.59],0.9173680955568092
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20534,54,0.86 [0.52-1.43],0.5632771459987025
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22751,93,0.76 [0.55-1.06],0.1017080639975674
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23526,868,0.78 [0.70-0.88],2.3023179940479576e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23066,408,0.77 [0.65-0.91],0.0026985020382642
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23732,288,0.81 [0.66-0.99],0.0360265821453665
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18832,1880,0.86 [0.79-0.93],0.0003672465596125
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,17004,52,1.07 [0.60-1.92],0.8134960290593543
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20563,83,0.79 [0.54-1.15],0.221556529852322
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,17007,55,0.90 [0.54-1.48],0.6678350926823846
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16997,45,0.95 [0.53-1.71],0.8686622509641406
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22845,187,0.79 [0.62-1.01],0.0591720671601624
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22820,162,0.88 [0.66-1.18],0.3921391905580785
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23781,85,0.83 [0.57-1.22],0.3444972936557849
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22284,1525,0.87 [0.79-0.95],0.0034249884599793
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20546,66,0.76 [0.51-1.13],0.1771383800901619
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16993,41,0.86 [0.49-1.52],0.6048218338053404
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21376,617,0.90 [0.78-1.05],0.1911090465853491
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18663,1711,0.83 [0.77-0.91],4.595037075623168e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23524,57,0.65 [0.45-0.93],0.0200923758226657
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23798,63,0.92 [0.57-1.47],0.7141671862451064
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20561,81,0.92 [0.60-1.42],0.7154705592530249
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21463,983,0.85 [0.76-0.95],0.0051124850510483
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20576,96,0.68 [0.50-0.93],0.0157483849536496
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18158,1206,0.82 [0.74-0.91],0.0001753125910845
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22743,85,0.88 [0.59-1.31],0.5192858651590967
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20525,45,1.22 [0.64-2.33],0.5522135216863524
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20869,110,0.69 [0.52-0.92],0.0111003629657418
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20983,503,0.78 [0.67-0.90],0.001069721568647
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23659,192,0.77 [0.60-0.98],0.0361201125431828
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21237,478,0.82 [0.70-0.96],0.0138392716920429
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23741,282,0.80 [0.65-0.99],0.0356490552850861
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23801,38,0.65 [0.41-1.04],0.073565553452137
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20630,150,0.71 [0.55-0.91],0.0064985382007141
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19526,572,0.81 [0.70-0.94],0.0051913871966653
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20961,481,0.85 [0.72-1.00],0.0514332293716183
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20810,330,0.94 [0.76-1.17],0.6005594396942506
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16982,30,0.66 [0.40-1.08],0.0977843031606644
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19225,2273,0.82 [0.76-0.88],1.156855894545384e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17405,453,0.84 [0.71-1.00],0.049443661291958
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23628,161,0.77 [0.59-1.01],0.0612450268705983
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23743,47,0.87 [0.51-1.49],0.6182781920613303
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21830,44,0.98 [0.53-1.79],0.9372879830842968
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,17017,65,0.90 [0.57-1.44],0.6697712820208377
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20846,87,0.82 [0.56-1.19],0.2873879844132411
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,17248,296,0.78 [0.64-0.95],0.0117647624280991
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20760,280,0.80 [0.65-0.99],0.0377356117699112
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20976,217,0.80 [0.63-1.01],0.0659719556550707
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20852,93,0.77 [0.54-1.10],0.1512445329158851
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18907,31,0.55 [0.36-0.85],0.0072286012796819
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23802,39,0.70 [0.43-1.14],0.1544643197066044
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21011,531,0.77 [0.67-0.89],0.000424589062467
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23487,20,0.60 [0.34-1.08],0.0904138254085241
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22744,2264,0.86 [0.80-0.93],0.000205946070249
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20586,106,0.72 [0.53-0.97],0.0325928798366274
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21265,506,0.92 [0.78-1.10],0.370480866386958
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22748,197,0.71 [0.57-0.88],0.0021751376061741
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20888,129,0.92 [0.66-1.29],0.6334807930472606
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22074,1315,0.85 [0.77-0.94],0.0015252542770843
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21580,821,0.91 [0.80-1.04],0.1833011241490408
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20523,43,0.66 [0.43-1.02],0.062888934510239
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23506,39,0.61 [0.41-0.92],0.0174915726032257
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20596,116,1.11 [0.75-1.64],0.5987899876139982
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20503,23,0.70 [0.37-1.31],0.2589688688813498
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),17012,60,1.24 [0.70-2.20],0.4581585451829358
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22802,1870,0.79 [0.73-0.86],1.447275557771039e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23340,406,0.82 [0.69-0.97],0.0216167969746207
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23070,136,0.86 [0.63-1.18],0.356649257634906
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22488,1556,0.84 [0.77-0.92],0.0001618477919499
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23563,86,0.88 [0.59-1.31],0.5319358113721032
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23533,362,0.78 [0.66-0.94],0.0083760115473138
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Cystitis,20937,211,0.99 [0.75-1.30],0.9171757744655432
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Dialysis,21037,105,0.78 [0.57-1.08],0.129733275535238
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22532,3315,0.93 [0.87-0.99],0.0286548484388044
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21442,5588,0.89 [0.85-0.94],9.9924899328776e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23580,103,0.75 [0.55-1.02],0.068217116330916
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Hydrocele,19424,207,1.03 [0.78-1.37],0.8191065621925613
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21039,373,0.84 [0.70-1.01],0.0636118597107639
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21830,2613,0.90 [0.84-0.97],0.0068877342966385
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19449,232,1.00 [0.77-1.30],0.9795097284637088
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20804,78,1.03 [0.66-1.62],0.8919017822155065
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19325,108,0.81 [0.58-1.13],0.2154276309954472
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23804,61,1.60 [0.88-2.92],0.1270013423411417
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23809,58,0.79 [0.51-1.25],0.3185907864101565
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22981,2255,0.87 [0.81-0.94],0.0007153199946228
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21680,954,0.88 [0.78-0.99],0.0408053523014963
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23740,569,0.78 [0.68-0.90],0.0006394771090438
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19523,306,0.85 [0.69-1.04],0.1076207585389863
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19494,277,0.93 [0.74-1.16],0.5142272473104358
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19447,230,0.92 [0.72-1.19],0.5269631175843503
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23799,49,0.85 [0.51-1.41],0.5177546114316398
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22263,1537,0.81 [0.74-0.89],3.8758098297637385e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21085,419,0.87 [0.73-1.04],0.119499405965523
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23362,191,0.72 [0.57-0.91],0.0054204097317772
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23536,59,0.70 [0.47-1.03],0.0733146029795385
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19482,265,1.04 [0.81-1.33],0.7649726983795269
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23513,2847,0.85 [0.79-0.90],1.1369346298909218e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",20740,74,1.01 [0.64-1.61],0.9561369028560168
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21090,158,0.76 [0.58-0.99],0.044684726771816
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23012,78,0.84 [0.56-1.26],0.3982168919842614
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21023,297,1.07 [0.84-1.35],0.5969448306237246
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23457,523,0.84 [0.72-0.98],0.028286889330043
